Didesmethylrocaglamide is a potent inhibitor of eukaryotic initiation factor 4A (eIF4A) with significant antitumor activity; it inhibits multiple pro-growth signaling pathways, induces apoptosis in tumor cells, and suppresses cell proliferation by causing G2/M cell cycle arrest and subsequent cell death; it also activates the DNA damage response and downregulates oncogenic kinases such as insulin-like growth factor-1 receptor.